Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

24. Oktober 2024 09:59 ET | Quelle: Research and Markets

Eculizumab (Soliris) Biosimilars & Biosuperiors Pipeline Review 2024: Drug Code/INN, Patent/Expiry, Target(s)/MoA, Class of Compound, Territory of Main Competitor, Indication(s) & R&D Stage

Dublin, Oct. 24, 2024 (GLOBE NEWSWIRE) -- The "Eculizumab (Soliris) Biosimilars & Biosuperiors Pipeline Review" report has been added to ResearchAndMarkets.com's offering.This product provides...
23. Februar 2024 07:31 ET | Quelle: Research and Markets

Eculizumab (Soliris) Biosimilars & Biosuperiors Pipeline Review 2024

Dublin, Feb. 23, 2024 (GLOBE NEWSWIRE) -- The "Eculizumab (Soliris) Biosimilars & Biosuperiors Pipeline Review" report has been added to ResearchAndMarkets.com's offering.This product provides...
14. Dezember 2023 10:43 ET | Quelle: Research and Markets

EMPAVELI (Pegcetacoplan) Drug Insight and Market Forecasts, 2019-2022 and 2023-2032

Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "EMPAVELI Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...